Cargando…

Managing patient pathways to achieve lung cancer waiting time targets: mixed methods study

OBJECTIVES: England's National Health Service (NHS) introduced a 62-day target, from referral to treatment, to make lung cancer patient pathways more efficient. This study aims to understand pathway delays that lead to breaches of the target when patients need care in both secondary and tertiar...

Descripción completa

Detalles Bibliográficos
Autores principales: Ip, Hugh, Amer, Tarik, Dangoor, Michael, Zamir, Affan, Gibbings-Isaac, Darryl, Kochhar, Ranjeev, Heymann, Timothy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal Society of Medicine Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499958/
https://www.ncbi.nlm.nih.gov/pubmed/23162682
http://dx.doi.org/10.1258/shorts.2012.012058
_version_ 1782250038477455360
author Ip, Hugh
Amer, Tarik
Dangoor, Michael
Zamir, Affan
Gibbings-Isaac, Darryl
Kochhar, Ranjeev
Heymann, Timothy
author_facet Ip, Hugh
Amer, Tarik
Dangoor, Michael
Zamir, Affan
Gibbings-Isaac, Darryl
Kochhar, Ranjeev
Heymann, Timothy
author_sort Ip, Hugh
collection PubMed
description OBJECTIVES: England's National Health Service (NHS) introduced a 62-day target, from referral to treatment, to make lung cancer patient pathways more efficient. This study aims to understand pathway delays that lead to breaches of the target when patients need care in both secondary and tertiary setting, so more than one institution is involved. DESIGN: Mixed methods cross case analysis. SETTING: Two tertiary referral hospitals in London. PARTICIPANTS: Database records of 53 patients were analysed. Nineteen sets of patient notes were used for pathway mapping. Seventeen doctors, four nurses, eight managers and administrators were interviewed. MAIN OUTCOME MEASURES: Qualitative methods include pathway mapping and semi-structured interviews. Quantitative analysis of patient pathway times from cancer services records. RESULTS: The majority of the patient pathway (68.4%) is spent in secondary centres. There is more variability in the processes of secondary centres but tertiary centres do not have perfect processes either. Three themes emerged from discussions: information flows, pathway performance and the role of the multidisciplinary approach. CONCLUSIONS: The actions of secondary centres have a greater influence on whether a patient breaches the 62-day target, compared with tertiary centres. Nevertheless variability exists in both, with potential for improvement.
format Online
Article
Text
id pubmed-3499958
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Royal Society of Medicine Press
record_format MEDLINE/PubMed
spelling pubmed-34999582012-11-16 Managing patient pathways to achieve lung cancer waiting time targets: mixed methods study Ip, Hugh Amer, Tarik Dangoor, Michael Zamir, Affan Gibbings-Isaac, Darryl Kochhar, Ranjeev Heymann, Timothy JRSM Short Rep Research OBJECTIVES: England's National Health Service (NHS) introduced a 62-day target, from referral to treatment, to make lung cancer patient pathways more efficient. This study aims to understand pathway delays that lead to breaches of the target when patients need care in both secondary and tertiary setting, so more than one institution is involved. DESIGN: Mixed methods cross case analysis. SETTING: Two tertiary referral hospitals in London. PARTICIPANTS: Database records of 53 patients were analysed. Nineteen sets of patient notes were used for pathway mapping. Seventeen doctors, four nurses, eight managers and administrators were interviewed. MAIN OUTCOME MEASURES: Qualitative methods include pathway mapping and semi-structured interviews. Quantitative analysis of patient pathway times from cancer services records. RESULTS: The majority of the patient pathway (68.4%) is spent in secondary centres. There is more variability in the processes of secondary centres but tertiary centres do not have perfect processes either. Three themes emerged from discussions: information flows, pathway performance and the role of the multidisciplinary approach. CONCLUSIONS: The actions of secondary centres have a greater influence on whether a patient breaches the 62-day target, compared with tertiary centres. Nevertheless variability exists in both, with potential for improvement. Royal Society of Medicine Press 2012-10-15 /pmc/articles/PMC3499958/ /pubmed/23162682 http://dx.doi.org/10.1258/shorts.2012.012058 Text en © 2012 Royal Society of Medicine Press http://creativecommons.org/licenses/by-nc/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/2.0/), which permits non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Ip, Hugh
Amer, Tarik
Dangoor, Michael
Zamir, Affan
Gibbings-Isaac, Darryl
Kochhar, Ranjeev
Heymann, Timothy
Managing patient pathways to achieve lung cancer waiting time targets: mixed methods study
title Managing patient pathways to achieve lung cancer waiting time targets: mixed methods study
title_full Managing patient pathways to achieve lung cancer waiting time targets: mixed methods study
title_fullStr Managing patient pathways to achieve lung cancer waiting time targets: mixed methods study
title_full_unstemmed Managing patient pathways to achieve lung cancer waiting time targets: mixed methods study
title_short Managing patient pathways to achieve lung cancer waiting time targets: mixed methods study
title_sort managing patient pathways to achieve lung cancer waiting time targets: mixed methods study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499958/
https://www.ncbi.nlm.nih.gov/pubmed/23162682
http://dx.doi.org/10.1258/shorts.2012.012058
work_keys_str_mv AT iphugh managingpatientpathwaystoachievelungcancerwaitingtimetargetsmixedmethodsstudy
AT amertarik managingpatientpathwaystoachievelungcancerwaitingtimetargetsmixedmethodsstudy
AT dangoormichael managingpatientpathwaystoachievelungcancerwaitingtimetargetsmixedmethodsstudy
AT zamiraffan managingpatientpathwaystoachievelungcancerwaitingtimetargetsmixedmethodsstudy
AT gibbingsisaacdarryl managingpatientpathwaystoachievelungcancerwaitingtimetargetsmixedmethodsstudy
AT kochharranjeev managingpatientpathwaystoachievelungcancerwaitingtimetargetsmixedmethodsstudy
AT heymanntimothy managingpatientpathwaystoachievelungcancerwaitingtimetargetsmixedmethodsstudy